30% off. Use code SUMMER30 at checkout for 30% off for 12 months on Pro and Premium subscriptions. Subscribe now

Gline Matthew

Insider profile

Performance

Overall performance
2.3

Performance over holding periods
4.2
30 days 90 days 120 days
Average return -5% 8.2% 15.1%
Success rate 45% 68% 82%
Transactions
7 14% Buy
34 71% Buy
47 69% Buy
Performance for realised trades
4.4
Average return 44%
Success rate 73%
Average holding period 220
Transactions 28
Gline Matthew's trades of Roivant Sciences Ltd's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-04-20 2026-04-16 S Sale
36,651 +39.8%
33.29
US$2,160,931
36,651 +39.8% 33.29 US$2,160,931
2026-04-16 2026-04-16 PrS Proposed sale
2,327
264.67
US$2,936,296
2,327 264.67 US$2,936,296
2026-04-16 2026-04-16 PrS Proposed sale
2,599
146.17
US$1,983,518
2,599 146.17 US$1,983,518
2025-12-17 2025-12-15 S Sale
943,527 -4.8%
21.68
US$20,455,665
943,527 -4.8% 21.68 US$20,455,665
2025-12-17 2025-12-15 S Sale
566,116 -3.0%
21.68
US$12,273,395
566,116 -3.0% 21.68 US$12,273,395
2025-12-17 2025-12-15 S Sale
230,357 -1.3%
21.68
US$4,994,140
230,357 -1.3% 21.68 US$4,994,140
2025-12-15 2025-12-15 PrS Proposed sale
1,740,000
21.68
US$37,723,200
1,740,000 21.68 US$37,723,200
2025-12-15 2025-12-15 PrS Proposed sale
1,740,000
21.68
US$37,723,200
1,740,000 21.68 US$37,723,200
2025-09-18 2025-09-18 B Purchase
3,315 +0.0%
15.07
US$49,957
3,315 +0.0% 15.07 US$49,957
2024-09-24 2024-09-23 S Sale
1,983,257 -10.0%
11.79
US$23,382,600
1,983,257 -10.0% 11.79 US$23,382,600
2024-09-23 2024-09-23 PrS Proposed sale
1,983,257
11.79
US$23,383,088
1,983,257 11.79 US$23,383,088
2023-11-21 2023-11-21 PrS Proposed sale
19,792
8.80
US$174,170
19,792 8.80 US$174,170
2023-10-23 2023-10-23 PrS Proposed sale
19,792
9.66
US$191,191
19,792 9.66 US$191,191
2023-09-28 2023-09-28 PrS Proposed sale
10,243
13.19
US$135,105
10,243 13.19 US$135,105
2023-09-21 2023-09-21 PrS Proposed sale
19,792
10.33
US$204,451
19,792 10.33 US$204,451
2023-08-28 2023-08-28 PrS Proposed sale
12,088
11.14
US$134,660
12,088 11.14 US$134,660
2023-08-21 2023-08-21 PrS Proposed sale
19,792
10.87
US$215,139
19,792 10.87 US$215,139
2023-07-28 2023-07-28 PrS Proposed sale
23,149
10.80
US$250,009
23,149 10.80 US$250,009
2023-07-21 2023-07-21 PrS Proposed sale
19,792
11.13
US$220,285
19,792 11.13 US$220,285
2023-06-21 2023-06-21 PrS Proposed sale
19,792
9.79
US$193,764
19,792 9.79 US$193,764
2023-05-30 2023-05-30 PrS Proposed sale
53,281
9.31
US$496,046
53,281 9.31 US$496,046
2023-05-22 2023-05-22 PrS Proposed sale
35,032
9.32
US$326,498
35,032 9.32 US$326,498
2022-10-27 2022-10-25 PlS Planned sale
19,276 -1.6%
4.40
US$84,814
19,276 -1.6% 4.40 US$84,814
2022-09-27 2022-09-23 PlS Planned sale
21,053 -1.7%
3.07
US$64,633
21,053 -1.7% 3.07 US$64,633
2022-08-26 2022-08-24 PlS Planned sale
20,009 -1.6%
3.71
US$74,233
20,009 -1.6% 3.71 US$74,233
2022-07-27 2022-07-25 PlS Planned sale
20,455 -1.6%
4.33
US$88,570
20,455 -1.6% 4.33 US$88,570
2022-06-27 2022-06-23 PlS Planned sale
19,855 -1.6%
4.34
US$86,171
19,855 -1.6% 4.34 US$86,171
2022-05-24 2022-05-20 S Sale
139,791 -10.0%
3.70
US$517,227
139,791 -10.0% 3.70 US$517,227
2022-04-27 2022-04-25 PlS Planned sale
8,509 -0.6%
3.84
US$32,675
8,509 -0.6% 3.84 US$32,675
2022-04-01 2022-03-30 PlS Planned sale
33,686 -2.3%
4.84
US$163,040
33,686 -2.3% 4.84 US$163,040
2022-03-29 2022-03-25 PlS Planned sale
35,386 -2.3%
5.06
US$179,053
35,386 -2.3% 5.06 US$179,053
2022-03-22 2022-03-18 PlS Planned sale
82,006 -5.2%
5.13
US$420,691
82,006 -5.2% 5.13 US$420,691
2022-03-09 2022-03-07 PlS Planned sale
92,324 -5.5%
5.52
US$509,628
92,324 -5.5% 5.52 US$509,628